{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Evexia Lifecare Ltd
Evexia Lifecare Ltd is Rated Strong Sell
Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 April 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Why is Evexia Lifecare Ltd falling/rising?
On 20-Jan, Evexia Lifecare Ltd’s stock price fell by 2.44% to ₹1.60, continuing a downward trend driven by deteriorating financial performance and weak investor sentiment.
Evexia Lifecare Ltd is Rated Strong Sell
Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 April 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Evexia Lifecare Ltd is Rated Strong Sell
Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 April 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics presented here are based on the stock's current position as of 03 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Evexia Lifecare Sees Revision in Market Evaluation Amid Challenging Financial Trends
Evexia Lifecare, a microcap player in the edible oil sector, has experienced a notable revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment comes amid persistent financial challenges and subdued stock performance over recent periods.
Evexia Lifecare Sees Revision in Market Assessment Amid Challenging Fundamentals
Evexia Lifecare, a microcap player in the edible oil sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. This shift highlights the company’s current standing amid a difficult market environment and subdued performance indicators.
Why is Evexia Lifecare falling/rising?
As of 19-Nov, Evexia Lifecare Ltd's stock is priced at Rs. 1.68, down 2.33%, and has reached a 52-week low of Rs. 1.52. The stock has underperformed significantly, declining 51.30% year-to-date, while the Sensex has gained 9.02%.
Evexia Lifecare Stock Falls to 52-Week Low of Rs.1.52 Amidst Continued Downtrend
Evexia Lifecare, a player in the edible oil sector, has touched a new 52-week low of Rs.1.52 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions.
Evexia Lifecare Faces Significant Financial Challenges Amidst Market Resilience
Evexia Lifecare, a microcap in the edible oil sector, has reported significant financial challenges for the quarter ending September 2025, with a 66.50% drop in profit after tax and a low operating profit to net sales ratio. The company's stock has also faced substantial declines over the past year.
How has been the historical performance of Evexia Lifecare?
Evexia Lifecare's historical performance shows significant sales growth from 56.29 Cr in Mar'24 to 110.48 Cr in Mar'25, despite previous declines. While operating profit improved, profitability metrics decreased, and total liabilities rose, indicating a mixed financial outlook.
How has been the historical performance of Evexia Lifecare?
Evexia Lifecare's historical performance shows significant fluctuations, with net sales increasing from INR 56.29 crore in March 2024 to INR 110.48 crore in March 2025, despite declines in profit after tax. Overall, the company has experienced a recovery in sales and operating profit, while cash flow remains variable.
When is the next results date for Evexia Lifecare?
The next results date for Evexia Lifecare is 14 November 2025.
Why is Evexia Lifecare falling/rising?
As of 28-Oct, Evexia Lifecare Ltd's stock price is 1.76, down 0.56%, with a significant decline of 13.73% over the past week and trading below all major moving averages, indicating a bearish trend. Despite increased investor participation, the stock's year-to-date decline of 48.99% contrasts sharply with the Sensex's gain of 8.30%, reflecting a challenging performance relative to the market.
Why is Evexia Lifecare falling/rising?
As of 24-Oct, Evexia Lifecare Ltd's stock price is Rs. 1.86, down 6.06%, marking a new 52-week low and significant underperformance with a year-to-date decline of 46.09%. Despite increased investor participation, the stock remains below all moving averages, indicating a bearish trend amidst a generally positive broader market.
Evexia Lifecare Stock Hits New 52-Week Low at Rs. 1.65
Evexia Lifecare, a microcap in the edible oil sector, has hit a new 52-week low, reflecting a significant decline in stock performance. Over the past year, the company has faced a substantial drop, underperforming its sector and struggling with high debt and low profitability, alongside minimal sales growth.
Is Evexia Lifecare overvalued or undervalued?
As of October 23, 2025, Evexia Lifecare is considered overvalued with a high PE ratio of 212.41 and an EV to EBITDA ratio of 206.57, significantly contrasting with its peers, and has underperformed the market with a year-to-date decline of 42.61%.
Evexia Lifecare Adjusts Valuation Amidst Declining Stock Performance and Profitability Concerns
Evexia Lifecare, a microcap in the edible oil sector, has adjusted its valuation amid a challenging year, with its stock down 47.20%. Key financial metrics indicate high valuations relative to earnings and low profitability, contrasting sharply with more favorable metrics from competitors like GP Petroleums and Continental Petroleums.
Is Evexia Lifecare overvalued or undervalued?
As of October 14, 2025, Evexia Lifecare is considered overvalued with a PE ratio of 214.55 and an EV to EBITDA of 207.60, significantly higher than industry peers like Castrol India and Gulf Oil Lubricants, while also underperforming the Sensex with a year-to-date return of -42.03%.
Evexia Lifecare Adjusts Valuation Amidst Declining Stock Performance and High Multiples
Evexia Lifecare, a microcap in the edible oil sector, has adjusted its valuation, currently priced at 2.00. The company has faced a notable decline in stock performance over the past year, with a high price-to-earnings ratio of 214.55, indicating a premium compared to its peers.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
